These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 640048

  • 21. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 22. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR, Parker CR, Madden JD, MacDonald PC, Porter JC.
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [Abstract] [Full Text] [Related]

  • 23. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Am J Obstet Gynecol; 1980 Oct 15; 138(4):383-90. PubMed ID: 6775535
    [Abstract] [Full Text] [Related]

  • 24. [Hypophyseal reaction state during oral contraceptiva (author's transl)].
    Gitsch E, Schneider WH, Schmid R, Spona J.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):599-601. PubMed ID: 6798764
    [Abstract] [Full Text] [Related]

  • 25. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr 16; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

  • 26. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH, Schmid R, Spona J.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):601-4. PubMed ID: 6798765
    [Abstract] [Full Text] [Related]

  • 27. Patterns of circulating gonadotropins (LH and FSH), prolactin and ovarian steroids (estradiol and progesterone) during the menstrual cycle in Korean women.
    Ryu K, Bokza B, Kim K.
    Yonsei Med J; 1979 Oct 16; 20(2):155-61. PubMed ID: 121822
    [No Abstract] [Full Text] [Related]

  • 28. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
    Korkhov VV, Nikanorova SA.
    Farmakol Toksikol; 1987 Oct 16; 50(1):97-100. PubMed ID: 3556564
    [Abstract] [Full Text] [Related]

  • 29. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J.
    Fertil Steril; 1993 Oct 16; 60(4):610-5. PubMed ID: 8405512
    [Abstract] [Full Text] [Related]

  • 30. The effect of ethinyl estradiol administration during the follicular phase of the menstrual cycle on LH, FSH, progesterone and estradiol levels in the subsequent luteal phase.
    Dhont M, Vandekerckhove D, Vermeulen A.
    J Clin Endocrinol Metab; 1974 Sep 16; 39(3):465-70. PubMed ID: 4416191
    [No Abstract] [Full Text] [Related]

  • 31. Effects of norgestrel and ethinyloestradiol ingestion on serum levels of sex hormones and gonadotrophins in men.
    Kjeld JM, Puah CM, Kaufman B, Loizou S, Vlotides J, Gwee HM, Kahn F, Sood R, Joplin GF.
    Clin Endocrinol (Oxf); 1979 Nov 16; 11(5):497-504. PubMed ID: 519881
    [No Abstract] [Full Text] [Related]

  • 32. [The effect of different types of oral contraceptives upon ovarian function (author's transl)].
    Aktories K, Krög W, Dericks-Tan JS, Jürgensen O, Taubert HD.
    Geburtshilfe Frauenheilkd; 1976 Apr 16; 36(4):318-26. PubMed ID: 1269893
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun 16; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
    Thomas KH, Vankrieken L.
    Int J Fertil; 1989 Sep 16; 34 Suppl():10-21. PubMed ID: 2576249
    [Abstract] [Full Text] [Related]

  • 35. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
    Snowden EU, Khan-Dawood FS, Dawood MY.
    Am J Obstet Gynecol; 1986 Feb 16; 154(2):440-4. PubMed ID: 3080893
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mechanism of the postcoital contraceptive effect of LH-RH in the rat. I. Serum hormone levels during chronic LH-RH Administration.
    Beattie CW, Corbin A, Cole G, Corry S, Jones RC, Koch K, Tracy J.
    Biol Reprod; 1977 Apr 16; 16(3):322-32. PubMed ID: 321040
    [Abstract] [Full Text] [Related]

  • 39. Plasma hormones in clomiphene citrate therapy.
    Wu CH.
    Obstet Gynecol; 1977 Apr 16; 49(4):443-8. PubMed ID: 857209
    [Abstract] [Full Text] [Related]

  • 40. Periovulatory hormonal dynamics: relationship of immunoassayable gonadotropins and ovarian steroids to the bioassayable luteinizing hormone surge in rhesus monkeys.
    Schenken RS, Werlin LB, Williams RF, Prihoda TJ, Hodgen GD.
    J Clin Endocrinol Metab; 1985 May 16; 60(5):886-90. PubMed ID: 3920234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.